Transcription of IMPORTANT SAFETY INFORMATION Billing and Coding Guide
{{id}} {{{paragraph}}}
INDICATIONSI njectafer (ferric carboxymaltose injection) is an iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in adult patients: who have intolerance to or have had unsatisfactory response to oral ironor who have non-dialysis dependent chronic kidney diseaseCONTRAINDICATIONSI njectafer is contraindicated in patients with hypersensitivity to Injectafer or any of its inactive and Coding Guide Please see attached Full Prescribing INFORMATION for Injectafer andImportant SAFETY INFORMATION on Page Regent is a registered trademark of Luitpold Pharmaceuticals, and the Injectafer logo are trademarks of Vifor (International), Inc.
the treatment of iron deficiency anemia (IDA) in adult patients: Billing and Coding Guide ® ® †‡ † ‡ IMPORTANT SAFETY INFORMATION
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}